Global Fund Board
The Global Fund Board will not approve funding for Phase 2 of a Round 8 health systems strengthening (HSS) grant in Guinea-Bissau. The Board’s No-Go decision follows notice of an intent to recommend a No-Go for this grant provided by the Global Fund Secretariat in October 2012 (see GFO article).
Given India’s economic status, the government should assume greater responsibility for TB programmes, and should ultimately assume full responsibility.
Five Concept Notes from Early Applicants Have Been Endorsed, and Have Moved to the Grant-Making Stage
Five concept notes submitted by early applicants have been endorsed by the Grant Approvals Committee (GAC). Three of the concept notes are from the country coordinating mechanism (CCM) in Myanmar (one for each disease). The others are from CCMs in El Salvador (HIV) and Zimbabwe (HIV). This information was contained in the 15 May issue of the Global Fund’s News Flash.
Communities and NGO Delegations Seek More Information on Funding Allocations for the Transition Phase of the NFM
The Communities and NGO delegations on the Global Fund Board have written to Executive Director Mark Dybul seeking clarification and additional information on how funding was allocated to early and interim applicants in the transition phase of the new funding model (NFM).
The Grants Renewal Panel says that overall performance of a single-stream-of-funding TB grant in Nepal has been high and that there is an opportunity for scale-up in the next implementation period.
Changes to the charter of the Office of the Inspector General (OIG) adopted by the Global Fund Board specify that when the OIG conducts country audits, it will not evaluate programme impact.
The Global Fund Board has appointed Dr Nafsiah Mboi, Minister of Health in Indonesia, as the next Chair of the Board. It has also appointed Mireille Guigaz as the next Vice-Chair. Ms Guigaz currently represents France on the Board. Dr Mboi does not currently sit on the Board. Both appointments are effective at the end of the 29th Board meeting in June 2013; the two terms will run until the end of the first Board meeting in 2015.
The Global Fund Board has approved Phase 2 funding for a Round 9 HIV grant in Bosnia and Hercegovina in the amount of $13.5 million. The principal recipient (PR) for the grant is the United Nations Development Programme (UNDP). UNDP is also PR for another HIV grant, which has been essentially completed, and for a TB grant in Bosnia and Hercegovina.
The Global Fund Board has approved Phase 2 funding for a Round 2 malaria rolling continuation channel grant in Namibia. The principal recipient (PR) for this grant is the National Malaria Control Programme (NMCP) in the Ministry of Health and Social Services. In approving the Phase 2 funding, the Board was acting on recommendations from the Grants Renewal Panel in the Secretariat.
The Global Fund Board has approved Phase 2 funding for two Round 9 HIV grants in Pakistan. Funding of $7.1 million was approved for one of the grants, for which the principal recipient (PR) is the National AIDS Control Programme. Funding of $11.3 million was approved for the other grant, for which the PR is the Nai Zindagi Trust.